These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29397905)

  • 21. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a.
    Mathew A; Kurane I; Rothman AL; Zeng LL; Brinton MA; Ennis FA
    J Clin Invest; 1996 Oct; 98(7):1684-91. PubMed ID: 8833919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. M cells expressing the complement C5a receptor are efficient targets for mucosal vaccine delivery.
    Kim SH; Jung DI; Yang IY; Kim J; Lee KY; Nochi T; Kiyono H; Jang YS
    Eur J Immunol; 2011 Nov; 41(11):3219-29. PubMed ID: 21887786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phage Display-Derived Ligand for Mucosal Transcytotic Receptor GP-2 Promotes Antigen Delivery to M Cells and Induces Antigen-Specific Immune Response.
    Khan IU; Huang J; Liu R; Wang J; Xie J; Zhu N
    SLAS Discov; 2017 Aug; 22(7):879-886. PubMed ID: 28346102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen.
    Alves RPDS; Pereira LR; Fabris DLN; Salvador FS; Santos RA; Zanotto PMA; Romano CM; Amorim JH; Ferreira LCS
    Clin Vaccine Immunol; 2016 Jun; 23(6):460-469. PubMed ID: 27030586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The early activation of CD8+ T cells is dependent on type I IFN signaling following intramuscular vaccination of adenovirus vector.
    Hemmi M; Tachibana M; Tsuzuki S; Shoji M; Sakurai F; Kawabata K; Kobiyama K; Ishii KJ; Akira S; Mizuguchi H
    Biomed Res Int; 2014; 2014():158128. PubMed ID: 24971314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of Cellular Immunity Associated with Experimental Infection with rDEN2Δ30 (Tonga/74) Support Its Suitability as a Human Dengue Virus Challenge Strain.
    Grifoni A; Angelo M; Sidney J; Paul S; Peters B; de Silva AD; Phillips E; Mallal S; Diehl SA; Botten J; Boyson J; Kirkpatrick BD; Whitehead SS; Durbin AP; Sette A; Weiskopf D
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.
    Hertz T; Beatty PR; MacMillen Z; Killingbeck SS; Wang C; Harris E
    J Immunol; 2017 May; 198(10):4025-4035. PubMed ID: 28381638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral Delivery of Probiotics Expressing Dendritic Cell-Targeting Peptide Fused with Porcine Epidemic Diarrhea Virus COE Antigen: A Promising Vaccine Strategy against PEDV.
    Wang X; Wang L; Huang X; Ma S; Yu M; Shi W; Qiao X; Tang L; Xu Y; Li Y
    Viruses; 2017 Oct; 9(11):. PubMed ID: 29068402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice.
    Barfoed AM; Rodriguez F; Therrien D; Borrego B; Sobrino F; Kamstrup S
    Antiviral Res; 2006 Dec; 72(3):178-89. PubMed ID: 16890298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate.
    Bal J; Luong NN; Park J; Song KD; Jang YS; Kim DH
    Microb Cell Fact; 2018 Feb; 17(1):24. PubMed ID: 29452594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects.
    Guy B; Nougarede N; Begue S; Sanchez V; Souag N; Carre M; Chambonneau L; Morrisson DN; Shaw D; Qiao M; Dumas R; Lang J; Forrat R
    Vaccine; 2008 Oct; 26(45):5712-21. PubMed ID: 18762226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment and characterization of dengue virus type 2 nonstructural protein 1 specific T cell lines.
    Xiao-meng Y; Li-fang J; Yun-xia T; Yue Y; Wen-quan L; Dan-yun F
    Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):e75-80. PubMed ID: 20138364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvanting influenza hemagglutinin vaccine with a human pulmonary surfactant-mimicking synthetic compound SF-10 induces local and systemic cell-mediated immunity in mice.
    Kim H; Kimoto T; Sakai S; Takahashi E; Kido H
    PLoS One; 2018; 13(1):e0191133. PubMed ID: 29370185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-4 and IL-13 mediated down-regulation of CD8 expression levels can dampen anti-viral CD8⁺ T cell avidity following HIV-1 recombinant pox viral vaccination.
    Wijesundara DK; Jackson RJ; Tscharke DC; Ranasinghe C
    Vaccine; 2013 Sep; 31(41):4548-55. PubMed ID: 23933364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New perspectives in vaccine development: mucosal immunity to infections.
    McGhee JR; Kiyono H
    Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of M cells in infection and mucosal vaccines.
    Wang M; Gao Z; Zhang Z; Pan L; Zhang Y
    Hum Vaccin Immunother; 2014; 10(12):3544-51. PubMed ID: 25483705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities.
    Livingston PG; Kurane I; Dai LC; Okamoto Y; Lai CJ; Men R; Karaki S; Takiguchi M; Ennis FA
    J Immunol; 1995 Feb; 154(3):1287-95. PubMed ID: 7529799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intramuscular DNA immunization with in vivo electroporation induces antigen-specific cellular and humoral immune responses in both systemic and gut-mucosal compartments.
    Shoji M; Katayama K; Tachibana M; Tomita K; Sakurai F; Kawabata K; Mizuguchi H
    Vaccine; 2012 Nov; 30(50):7278-85. PubMed ID: 23036499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.
    Garzón MR; Berraondo P; Crettaz J; Ochoa L; Vera M; Lasarte JJ; Vales A; Van Rooijen N; Ruiz J; Prieto J; Zulueta J; González-Aseguinolaza G
    Vaccine; 2005 Feb; 23(11):1384-92. PubMed ID: 15661387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New generation of mucosal adjuvants for the induction of protective immunity.
    Yuki Y; Kiyono H
    Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.